Quest Diagnostics (DGX) Depreciation and Depletion (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Depreciation and Depletion data on file, last reported at $110.0 million in Q1 2026.

• Quarterly Depreciation and Depletion rose 8.91% year-over-year to $110.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $425.0 million (up 11.84% YoY) and the FY2025 annual result came in at $416.0 million, up 13.66% from the prior year.
• Depreciation and Depletion climbed to $110.0 million in Q1 2026 per DGX's latest filing, from $108.0 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $110.0 million in Q1 2026, with the low at $77.0 million in Q4 2022.
• Average Depreciation and Depletion over 5 years is $90.6 million, with a median of $87.0 million recorded in 2024.
• Year-over-year, Depreciation and Depletion dropped 3.75% in 2022 and climbed 19.51% in 2024.
• Quest Diagnostics' Depreciation and Depletion stood at $77.0 million in 2022, then climbed by 6.49% to $82.0 million in 2023, then gained by 19.51% to $98.0 million in 2024, then grew by 10.2% to $108.0 million in 2025, then climbed by 1.85% to $110.0 million in 2026.
• Business Quant data shows DGX's Depreciation and Depletion at $110.0 million in Q1 2026, $108.0 million in Q4 2025, and $103.0 million in Q3 2025.